Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model
about
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalCCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalAll-trans retinoic acid arrests cell cycle in leukemic bone marrow stromal cells by increasing intercellular communication through connexin 43-mediated gap junction.Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse modelsArsenic trioxide inhibits cancer stem-like cells via down-regulation of Gli1 in lung cancer.Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer.Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinomaCD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylationAntitumor activity and inhibitory effects on cancer stem cell-like properties of Adeno-associated virus (AAV) -mediated Bmi-1 interference driven by Bmi-1 promoter for gastric cancer.Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.Approaches for targeting cancer stem cells drug resistance.Association Between Expression of Cancer Stem Cell Markers and Poor Differentiation of Hepatocellular Carcinoma: A Meta-Analysis (PRISMA).Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma.
P2860
Q26744536-7393461E-7015-485E-BFE0-B488988E3084Q26779818-AC142F92-A009-436B-A00B-CC07ED404CC3Q26853543-AD872A45-030A-44AB-916B-FF06155720EFQ36134845-FAFFD8F8-CBF9-4E6A-93D8-A3EAE5EC668BQ36232448-DBB15B1F-E365-45C4-B6A2-3F3B34DE7C83Q36668116-575A2195-BBDA-4730-B920-D5051A1FBB50Q36841351-5E949BDA-54B9-4B05-9382-891F0FD9C967Q36962804-523A96EF-D95A-4FE5-A57B-C22674B7D212Q37064043-39E9F2BD-350B-44F6-AE75-D874BD534508Q37109585-4E3F1932-0E52-435C-9CDD-598E9ADAFE3BQ37225659-C515EEBE-2815-4CA1-93E7-BCD0668F4B66Q37362644-8B182A0E-E2FD-46C2-9958-E1BE2BAB8E8BQ38949050-E131F593-7D49-43AD-8772-A05B57A05D36Q38971795-9BCAB833-380B-447D-83A3-BF3A1830CFAAQ40648635-14E8BC83-6816-4C2D-B82B-CA8AD362F697Q53482041-CF0A5257-9966-459F-B7E1-BBC69DE51290
P2860
Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Arsenic trioxide induces diffe ...... I1 expression in a mouse model
@ast
Arsenic trioxide induces diffe ...... I1 expression in a mouse model
@en
type
label
Arsenic trioxide induces diffe ...... I1 expression in a mouse model
@ast
Arsenic trioxide induces diffe ...... I1 expression in a mouse model
@en
prefLabel
Arsenic trioxide induces diffe ...... I1 expression in a mouse model
@ast
Arsenic trioxide induces diffe ...... I1 expression in a mouse model
@en
P2093
P2860
P356
P1476
Arsenic trioxide induces diffe ...... I1 expression in a mouse model
@en
P2093
Hui-Chuan Sun
Jian-Yang Ao
Ke-Zhi Zhang
Ling-Qun Kong
Qiang-Bo Zhang
Quan-Bao Zhang
Xiao-Dong Zhu
Yuan-Yuan Zhang
P2860
P2888
P356
10.1186/1756-8722-7-28
P577
2014-03-30T00:00:00Z
P5875
P6179
1009047059